|
1
|
Kao JH and Chen DS: Global control of
hepatitis B virus infection. Lancet Infect Dis. 2:395–403. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liaw YF: Therapy of chronic hepatitis B:
current challenges and opportunities. J Viral Hepat. 9:393–399.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schütz K, Carle R and Schieber A:
Taraxacum - a review on its phytochemical and pharmacological
profile. J Ethnopharmacol. 107:313–323. 2006.PubMed/NCBI
|
|
4
|
Yarnell E and Abascal K: Dandelion
(Taraxacum officinale and T. mongolicum). Integr Med.
8:35–38. 2009.
|
|
5
|
Song L, Hong X and Ding X: Dictionary of
Modern Chinese Medicine. People’s Health Publishers; Beijing: pp.
22412001, (In Chinese).
|
|
6
|
Shi S, Zhou H, Zhang Y, Zhao Y, Huang K
and Liu S: A high-speed counter-current chromatography-HPLC-DAD
method for preparative isolation and purification of two
polymethoxylated flavones from Taraxacum mongolicum. J
Chromatogr Sci. 47:349–353. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ling Y, Bao Y, Guo X, Xu Y, Cai S and
Zheng J: Isolation and identification of two flavonoids from
Taraxacum mongolicum Hand.-Mazz. Zhongguo Zhong Yao Za Zhi.
24:225–226. 1999.(In Chinese).
|
|
8
|
Shi S, Zhang Y, Zhao Y and Huang K:
Preparative isolation and purification of three flavonoid
glycosides from Taraxacum mongolicum by high-speed
counter-current chromatography. J Sep Sci. 31:683–688. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shi S, Zhao Y, Zhou H, Zhang Y, Jiang X
and Huang K: Identification of antioxidants from Taraxacum
mongolicum by high-performance liquid chromatography-diode
array detection-radical-scavenging detection-electrospray
ionization mass spectrometry and nuclear magnetic resonance
experiments. J Chromatogr A. 1209:145–152. 2008.
|
|
10
|
Kim YH, Choo SJ, Ryoo IJ, Ahn JS and Yoo
ID: Eudesmanolides from Taraxacum mongolicum and their
inhibitory effects on the production of nitric oxide. Arch Pharm
Res. 34:37–41. 2011.
|
|
11
|
Kim DH and Kim SH: Antitumor activity of
Taraxacum mongolicum. J Korean Med Sci. 16:386–413.
1995.
|
|
12
|
Chen Z: Clinical study of 96 cases with
chronic hepatitis B treated with jiedu yanggan gao by a
double-blind method. Zhong Xi Yi Jie He Za Zhi. 10:71–74. 1990.(In
Chinese).
|
|
13
|
Singh M, Singh SS and Sanwal GG: A new
colorimetric method for the determination of pheonlics. Indian J
Exp Biol. 16:712–714. 1978.
|
|
14
|
Dewanto V, Wu X, Adom KK and Liu RH:
Thermal processing enhances the nutritional value of tomatoes by
increasing total antioxidant activity. J Agric Food Chem.
50:3010–3014. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Choudhary MI, Naheed N, Abbaskhan A,
Musharraf SG, Siddiqui H and Atta-Ur-Rahman: Phenolic and other
constituents of fresh water fern Salvinia molesta.
Phytochemistry. 69:1018–1023. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Barberán FA, Hernández L, Ferreres F and
Tomás F: Highly methylated 6-hydroxyflavones and other flavonoids
from Thymus piperella. Planta Med. 51:452–454.
1985.PubMed/NCBI
|
|
17
|
Anil Kumar PR, Menon Bindu, Anil Kumar TV
and Kumari TV: Culture of neonatal rat liver cells: a preliminary
observation. Trends Biomater Artif Organs. 16:34–47. 2002.
|
|
18
|
Borel C, Schorr O, Durand I, Zoulim F, Kay
A, Trepo C and Hantz O: Initial amplification of duck hepatitis B
virus covalently closed circular DNA after in vitro infection of
embryonic duck hepatocytes is increased by cell cycle progression.
Hepatology. 34:168–179. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Srivastava S, Srivastava AK, Srivastava S,
Patnaik GK and Dhawan BN: Effect of picroliv and silymarin on liver
regeneration in rats. Indian J Pharmacol. 26:19–22. 1994.
|
|
20
|
Hu HL and Chen RD: Changes in free
radicals, trace elements, and neurophysiological function in rats
with liver damage induced by D-galactosamine. Biol Trace Elem Res.
34:19–25. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Quintero A, Pedraza CA, Siendones E, et
al: PGE1 protection against apoptosis induced by D-galactosamine is
not related to the modulation of intracellular free radical
production in primary culture of rat hepatocytes. Free Radic Res.
36:345–355. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Akbay A, Cinar K, Uzunalimoğlu O, Eranil
S, Yurdaydin C, Bozkaya H and Bozdayi M: Serum cytotoxin and
oxidant stress markers in nacetylcysteine treated thioacetamide
hepatotoxicity of rats. Hum Exp Toxicol. 18:669–676. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cascales M, Martín-Sanz P, Craciunescu DG,
Mayo I, Aguilar A, Robles-Chillida EM and Cascales C: Alterations
in hepatic peroxidation mechanisms in thioacetamide-induced tumors
in rats. Effect of a rhodium (III) complex. Carcinogenesis.
12:233–240. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thornalley P, Trotta RJ and Stern A: Free
radical involvement in the oxidative phenomena induced by
tert-butyl hydroperoxide in erythrocytes. Biochem Biophys Acta.
759:16–22. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rush GF, Gorski JR, Ripple MG, Sowinski J,
Bugelski P and Hewitt WR: Organic hydroperoxide-induced lipid
peroxidation and cell death in isolated hepatocytes. Toxicol Appl
Pharmacol. 78:473–483. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mason WS, Seal G and Summers J: Virus of
Pekin ducks with structural and biological relatedness to human
hepatitis B virus. J Virol. 36:829–836. 1980.PubMed/NCBI
|
|
27
|
Summers J and Mason WS: Replication of the
genome of a hepatitis B-like virus by reverse transcription of an
RNA intermediate. Cell. 29:403–415. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Omata M, Uchiumi K, Ito Y, Yokosuka O,
Mori J, Terao K, Wei-Fa Y, O’Connell AP, London WT and Okuda K:
Duck hepatitis B virus and liver disease. Gastroenterology.
85:260–267. 1983.PubMed/NCBI
|
|
29
|
Duflot A, Mehrota R, Yu S, Barraud L,
Trepo C and Cova L: Spectrum of liver disease and duck hepatitis B
virus infection in a large series of Chinese ducks with
hepatocellular carcinoma. Hepatology. 21:1483–1491. 1995.PubMed/NCBI
|
|
30
|
Schultz U, Grgacic E and Nassal M: Duck
hepatitis B virus: an invaluable model system for HBV infection.
Adv Virus Res. 63:1–70. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sureau C, Romet-Lemonne JL, Mullins JI and
Essex M: Production of hepatitis B virus by a differentiated human
hepatoma cell line after transfection with cloned circular HBV DNA.
Cell. 47:37–47. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang RL, Chen CF, Feng HY, Lin LC and
Chou CJ: Anti-hepatitis B virus of seven compounds isolated from
Piper Kadsura (Choisy) Ohwi. Chin Med J. 12:179–190. 2001.
|
|
33
|
McDougall B, King PJ, Wu BW, Hostomsky Z,
Reinecke MG and Robinson WE Jr: Dicaffeoylquinic and
dicaffeoyltartaric acids are selective inhibitors of human
immunodeficiency virus type 1 integrase. Antimicrob Agents
Chemother. 42:140–146. 1998.PubMed/NCBI
|
|
34
|
Sandhar HK, Kumar B, Prasher S and Sharma
P: A review of phytochemistry and pharmacology of flavonoids. Int
Pharm Sci. 1:25–41. 2011.
|
